Clinical Trial Update: Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Alpha 1 Antitrypsin (AAT) for acute graft-versus-host disease (GVHD) after transplantation; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Alpha-1 Antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Graft-Versus-Host Disease (GVHD) Acute on Chronic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-10-30